Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Smoflipid

Other · developed by Fresenius Kabi Usa

Approved FDA, Jul 2016
FMS Developer
1 Registered trials

What is Smoflipid?

SMOFlipid is a lipid emulsion for intravenous infusion, containing soybean oil, MCT, olive oil and fish oil. It supplies calories and essential fatty acids, which are used for energy through beta oxidation and serve as membrane components and precursors of bioactive molecules. It is studied in malnutrition, essential fatty acid deficiency and parenteral nutrition associated cholestasis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Other
Pathways
beta oxidation, prostaglandin precursor supply, membrane structure and function, gene expression regulation
Therapy area
Metabolic
Developer
Fresenius Kabi Usa (FMS)
FDA status
Approved (July 13, 2016), NDA207648 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Aug 15, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06049680 Phase 4 Malnutrition, Child Recruiting FMS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Essential Fatty Acid Deficiency (EFAD)MalnutritionMalnutrition, ChildParenteral Nutrition Associated Cholestasis

More from Fresenius Kabi Usa

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the FMS page.

Follow FMS, the company behind Smoflipid

See FMS's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

FMS catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.